Calamos Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,014
Closed -$235K 318
2024
Q2
$235K Buy
1,014
+13
+1% +$2.83K 0.01% 272
2024
Q1
$216K Hold
1,001
0.01% 280
2023
Q4
$259K Hold
1,001
0.02% 261
2023
Q3
$257K Hold
1,001
0.02% 274
2023
Q2
$285K Buy
1,001
+1
+0.1% +$298 0.02% 265
2023
Q1
$278K Hold
1,000
0.02% 263
2022
Q4
$277K Hold
1,000
0.02% 270
2022
Q3
$267K Sell
1,000
-17
-2% -$3.61K 0.02% 264
2022
Q2
$207K Sell
1,017
-42
-4% -$8.59K 0.02% 300
2022
Q1
$223K Buy
1,059
+42
+4% +$9.13K 0.02% 312
2021
Q4
$244K Buy
+1,017
New +$261K 0.02% 301
2016
Q4
Sell
-2,277
Closed -$713K 224
2016
Q3
$713K Sell
2,277
-207
-8% -$61.3K 0.12% 165
2016
Q2
$601K Sell
2,484
-186
-7% -$49K 0.11% 168
2016
Q1
$695K Sell
2,670
-26
-1% -$6.87K 0.14% 171
2015
Q4
$826K Sell
2,696
-896
-25% -$257K 0.17% 166
2015
Q3
$1.05M Sell
3,592
-4,085
-53% -$1.35M 0.25% 133
2015
Q2
$3.1M Buy
7,677
+1,937
+34% +$777K 0.73% 38
2015
Q1
$2.42M Buy
5,740
+3,504
+157% +$1.38M 0.61% 51
2014
Q4
$759K Sell
2,236
-39
-2% -$12.6K 0.22% 152
2014
Q3
$753K Buy
2,275
+10
+0.4% +$3.3K 0.22% 149
2014
Q2
$714K Buy
2,265
+40
+2% +$12K 0.2% 160
2014
Q1
$681K Buy
2,225
+163
+8% +$51.7K 0.2% 158
2013
Q4
$577K Sell
2,062
-50
-2% -$12.9K 0.18% 168
2013
Q3
$508K Buy
2,112
+89
+4% +$19.9K 0.17% 168
2013
Q2
$435K Buy
+2,023
New +$432K 0.15% 165

Other funds holding BIIB